A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer

Basit Öğe Kaydı
dc.contributor.authorYalcin, S.
dc.contributor.authorUslu, R.
dc.contributor.authorDane, F.
dc.contributor.authorYilmaz, U.
dc.contributor.authorZengin, N.
dc.contributor.authorBuyukunal, E.
dc.contributor.authorBuyukberber, S.
dc.contributor.authorCamci, C.
dc.contributor.authorSencan, O.
dc.contributor.authorKilickap, S.
dc.date.accessioned2019-10-27T21:25:11Z
dc.date.available2019-10-27T21:25:11Z
dc.date.issued2011
dc.departmentEge Üniversitesien_US
dc.identifier.doi10.1200/jco.2011.29.4_suppl.474
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue4en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.4_suppl.474
dc.identifier.urihttps://hdl.handle.net/11454/44775
dc.identifier.volume29en_US
dc.identifier.wosWOS:000208847100471en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleA randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal canceren_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu